Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 05:21:46 +0200Thu, 04 Jul 2024 15:02:00 +0200Spikevax : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5791-en_3.pdfSpikevax : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5791-en_3.pdfThu, 04 Jul 2024 15:02:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine,elasomeran,elasomeran / imelasomeran,elasomeran / davesomeran,andusomeran, Date of authorisation: 06/01/2021, Revision: 46, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/spikevax-previously-covid-19-vaccine-modernaHuman medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine,elasomeran,elasomeran / imelasomeran,elasomeran / davesomeran,andusomeran, Date of authorisation: 06/01/2021, Revision: 46, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/spikevax-previously-covid-19-vaccine-modernaThu, 04 Jul 2024 10:38:00 +0200Human medicine